A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor

Semmelweis Egyetem, Budapest

Azienda Socio Sanitaria Territoriale Fatebenefratelli (Presidio Ospedale Sacco), Milan

Institute for Asthma & Allergy, P.C., Chevy Chase

Clinical Research Center of Alabama, Birmingham

Optimed Research, LTD, Columbus

Bernstein Clinical Research Center, LLC, Cincinnati

University of Michigan, Ann Arbor

Hospital Universitario Cruces, Barakaldo

Mayo Clinic, Rochester

Klinikum der Johann Wolfgang Goethe-Universitaet pt, Frankfurt am Main

Rush University Medical Center, Chicago

Washington University, St Louis

Kanarek Allergy, Asthma and Immunology, Overland Park

Hôpital Saint-Antoine, Paris

"Azienda Ospedaliera Universitaria Federico II", Napoli

Asthma and Allergy Associates, PC, Colorado Springs

Klinikum rechts der Isar der TU, Munich

Azienda Ospedaliera Universitaria OO. RR. S. Giovanni di Dio e Ruggi D'Aragona, Salerno

Medical Research of Arizona, Scottsdale

A.O. Ospedali riuniti Villa Sofia - Cervello,, Palermo

UCSD Angioedema Center, San Diego

Allergy and Asthma Clinical Research Inc, Walnut Creek

Seattle Allergy & Asthma Research Institute, Seattle

Massachusetts General Hospital, Boston

Ottawa Allergy Research Corporation, Ottawa

Clinique Specialisee en Allergie de la Capitale, Québec

Hiroshima University Hospital, Hiroshima

Kobe University Hospital, Kobe

Clover Hospital, Fujisawa-shi

Amsterdam UMC, Amsterdam

Universitair Medisch Centrum Groningen, Groningen

UMC Utrecht, Utrecht

NZOZ Homeo Medicus, Poradnia Alergologiczna, Bialystok

"ALL-MED Specjalistyczna Opieka Medyczna Filia", Wroclaw

Hospital Universitari Vall d'Hebron, Barcelona